Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
CMC1 pseudogene 2 (CMC1P2) is a non-coding genetic element similar in sequence to the functional CMC1 gene, which encodes a mitochondrial protein that participates in the early steps of cytochrome c oxidase complex assembly[1][2][3]. However, as a pseudogene, CMC1P2 does not produce a functional protein and has no known biological or therapeutic relevance, nor any established role in disease or drug interaction. The true functional protein, CMC1, is a mitochondrial intermembrane space protein critical for COX complex stability and assembly, but CMC1P2 itself does not share these functions. Key clarification: CMC1P2 is not a therapeutic target; it is a pseudogene (a genomic "copy" that is not translated into a functional protein). There may be confusion in databases or literature due to similarity in names with the functional CMC1 gene/protein, but only CMC1 (not CMC1P2) is functionally involved in COX assembly and potentially mitochondrial diseases[1][2][3]. If you are seeking information on the functional protein involved in COX assembly, refer instead to COX assembly mitochondrial protein 1 (CMC1) and not its pseudogenes.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on CMC1 pseudogene 2 (CMC1P2).